The global stem cell anticancer therapeutics market was valued at $859 million in 2010. This market is projected to increase at an 11.3% compound annual growth rate (CAGR) to reach more than $1.47 billion by 2015.
Learn about the human applications both marketed and in development of anti–cancer and tissue protective therapies and stem cell therapies for oncology conditions. BCC extensively analyzes each market segment, presents its current market status and presents various forecasts for growth over the next 5 years…
Use this report to:
- Analyze the current stem cell therapeutics oncology market in cancers such as multiple myeloma, leukemia, lymphoma, prostate, breast and lung cancers, and explore the future direction of these markets
- Develop business strategies based on an assessment of marketed and emerging stem cell therapies for oncology conditions by market segment, current status, and forecasts for growth over the next 5 years
- Identify and understand challenges to development including FDA restrictions, government legislation, and a cancer’s drug resistance to therapeutics
- Learn about the strategies of some of the more innovative companies and organizations with the savvy to produce revenue streams in this emerging, complex, and highly experimental market.
To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.
GLOBAL MARKET REVENUE FORECAST FOR STEM CELL THERAPEUTIC REGIMENS IN ONCOLOGY, 2008-2015